Because noncommunicable diseases such as type 2 diabetes mellitus have their roots in prenatal development and conditions such as maternal gestational diabetes mellitus (GDM), we aimed to test this hypothesis in primary cells derived from the offspring of mothers with GDM compared with control subjects. We have assessed primary umbilical cord-derived cells such as human umbilical vein endothelial cells (HUVECs) and Wharton's jelly-derived mesenchymal stem cells from the offspring of mothers with and without GDM. We have compared the primary isolates in cell-based assays measuring proliferation, mitochondrial oxygen consumption, and the ability to support blood vessel growth. We conducted gene expression microarray studies with subsequent pathway analysis and candidate gene validation. We observed striking differences between the two groups, such as lower metabolic rates and impairment of endothelial tube formation in cells with GDM background. HUVECs from subjects with maternal GDM have lower expression of the antiapoptotic protein BCL-xL, suggesting compromised angiogenic capabilities. Comparative gene expression analysis revealed blood vessel formation as a major pathway enriched in the GDM-derived HUVECs with the surface marker CD44 as a gene underexpressed in the GDM group. Functional validation of CD44 revealed that it regulates tube formation in HUVECs, thereby providing insights into a pathway imprinted in primary umbilical cord-derived cells from GDM offspring. Our data demonstrate that primary cells isolated from the umbilical cord of offspring born to mothers with GDM maintain metabolic and molecular imprints of maternal hyperglycemia, reflecting an increased risk for cardiovascular disease later in life. (Endocrinology 158: 2102(Endocrinology 158: -2112(Endocrinology 158: , 2017 
D
evelopmental fetal programming has been linked to increased risk for metabolic diseases such as type 2 diabetes mellitus, obesity, and cardiovascular disease (1) (2) (3) . Increased metabolic risk in the offspring is often brought about by maternal gestational diabetes mellitus (GDM) (4) , and apart from the well-documented short-term adverse obstetric and perinatal complications associated with GDM (5), long-term future metabolic health and neurodevelopmental implications for the offspring have been described (6) . Intrauterine exposure to maternal diabetes has also been linked to higher cardiovascular stress responses in the offspring (7) , and cardiovascular disease can become apparent in the form of endothelial dysfunction (ED) (8, 9) . Elevation of markers has been linked to inflammation and ED in umbilical cord blood (10) , and ED early in life may accelerate the onset of cardiovascular disease (11) , which is supported by the evidence that offspring of mothers with GDM have an elevated cardiovascular disease risk (12, 13) .
Clinical experimental research in the area of developmental origins of metabolic disease is hampered by the lack of human biological test systems, and we have shown previously that fetal cells residing in the umbilical cord can serve as surrogate models to study the effect of fetal growth restriction (14) (15) (16) . Other groups have recently reported that Wharton's jelly-derived mesenchymal stem cells (WJMSCs) derived from GDM offspring show lower metabolic activity and lower expression of genes important for mitochondrial function (17, 18) . Our study aimed to determine whether maternal hyperglycemia leaves a metabolic imprint in umbilical cord-derived cells and to identify molecular pathways playing a putative role in the etiology of metabolic diseases in the offspring. We observed that various cell types within the cord are affected by maternal hyperglycemia to different extents, as evidenced by altered expression of genes regulating key molecular pathways for cellular function with particular involvement in the homeostasis of cardiovascular health.
Materials and Methods

Clinical populations and sample collection
Fresh umbilical cords were obtained from children born at the National University Hospital (NUH), Singapore. Institutional review board approval by the National University Health System was granted before cord collection. Ethical approval was obtained by the Domain Specific Review Board (# 2011/00355) of NUH. All mothers diagnosed with GDM were recruited at the GDM clinic at NUH, whereas the normal controls were recruited at the NUH delivery suite.
Preparation and propagation of mesenchymal stem cells from human umbilical cord
WJMSCs were isolated from freshly obtained umbilical cords from babies born at NUH, and the protocol for harvest and preparation has been published by our laboratory and others before (14, 15, 19) .
Preparation of human umbilical vein endothelial cells
The protocols for human umbilical vein endothelial cell (HUVEC) isolation and culture was adapted and modified according to Crampton et al. (20) . Briefly, the vein was filled with a solution containing 1 mg/mL collagenase, the cord was incubated in prewarmed phosphate-buffered saline at 37°C for 30 minutes, and cells were taken up in endothelial cell growth media (EGM-2, LONZA, #CC-3162) and seeded on T75 culture flasks coated with gelatin (Sigma-Aldrich, #G1890). Magnetic cell sorting technology comprising an anti-CD31 monoclonal antibody coupled to magnetic beads (CD31 MicroBeads; Miltenyi Biotec, #130-091-935), followed by magnetic cell sorting column separation according to the manufacturer's protocol, was used to enrich for HUVEC cell fractions for further expansion.
Oxygen consumption rate
The oxygen consumption rate (OCR) of HUVECs and WJMSCs was measured with the Seahorse XF Cell Mito Stress Assay Kit (Seahorse Biosciences, #103015-100) according to the manufacturer's instructions.
Glucose uptake
HUVECs and WJMSCs were grown in 48-well plates and serum starved for 6 hours before treatment with medium containing 1 g/L of D-glucose or 1g/L D-glucose plus 100 nM insulin. The medium was collected after 6 hours and subjected to measurement with the QuantiChrom Glucose Assay Kit (Bioassay Systems, #DIGL-100) to determine the glucose content of the spent media according to the manufacturer's protocol.
Glucose and fatty acid in vitro exposure
Normal HUVECs were seeded in six-well plates at a seeding density of 120,000 per well and exposed to either low glucose (proprietary information of manufacturer, Lonza, EGM-2, #CC-3162) or high glucose (30 mmol/L D-glucose) for 6 to 24 hours. CD44 expression was determined by reverse transcription polymerase chain reaction (RT-PCR). Similarly, normal HUVECs were exposed to a fatty acid mixture of sodium oleate (Sigma, #O3880) and palmitic acid (Sigma, #P5585) in a 1:1 ratio at concentrations of 0.25 mM and 0.5 mM in a 7.5% BSA Fraction V solution (GIBCO 15620037) for 24 hours.
Cell proliferation assay
HUVECs were seeded at a seeding density of 4000 cells per well and WJMSCs at 5000 cells per well. Cells were allowed to attach and grow at 37°C and 5% CO 2 . Every 24 hours, the total quantity of viable cells per well was estimated by using the AlamarBlue® Cell Viability Reagent (Invitrogen, #DAL1025) according to the manufacturer's protocol.
Tube formation in vitro angiogenesis assay
Briefly, BD Matrigel TM reagent (Invitrogen) was precoated on the cell culture surface of six-well plates. After 1 hour, HUVECs were seeded onto the plate in triplicates. After incubation in a tissue culture incubator at 37°C, cell tube formation could be observed after 24 to 48 hours. Light microscopic photographs were taken, and the average number of branches and total tube length were calculated for each well via the angiogenesis plugin in the ImageJ program (21) .
Reactive oxygen species
Cells were seeded onto a 96 flat-bottom gelatin-precoated tissue culture plate at a seeding density of 30,000 cells per well in quadruplicates. Plates were incubated at 37°C overnight in a CO 2 incubator. The 2 0 ,7 0 -dichlorofluorescin diacetate kit (Abcam) was used to measure reactive oxygen species (ROS) according to the manufacturer's instructions.
Western blotting
Radioimmunoprecipitation assay buffer (50 mM TrisHCl pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 0.1% sodium dodecyl sulfate) along with 1X protease inhibitor was used to isolate the total cellular protein from the HUVECs, and extracted proteins were quantified via the Bradford method (Bio-Rad). Primary antibodies specific to CD44 (Thermo Fisher), BCL-xL (CST 2762S), BID (2002S), BAK (CST 3814S), BAX (CST 2772S), and endogenous control protein b-actin (Sigma, A1978, A5441) were used to probe the blots overnight at 4°C via routine western blot procedures.
RNA extraction
Cells were spun down in 1.7-mL tubes and resuspended in 0.5 mL of TRIzol® Reagent (Life Technologies, 15596-026). RNA isolation and purification followed the RNeasy Mini Kit (Qiagen, 74106) protocol.
Quantitative RT-PCR
Total RNA (1 to 2 mg) was reverse transcribed (High Capacity cDNA Reverse Transcription Kit, Applied Biosystems Inc.). Target-specific gene expression levels were measured in an ABI 7900 HT Sequence Detection System (Applied Biosystem Inc.), normalized to endogenous control genes (GAPDH or RPL18 and HSP90AB1), and presented relative to the controls. Sequences for primers used in the study are listed in Supplemental Table 5 .
Small interfering RNA-mediated candidate gene depletion
The CD44 gene was depleted with ON-TARGETplus Human CD44 small interfering RNA (siRNA) SMARTpool (Dharmacon, L-009999-00-0020) or, for control transfections, ON-TARGETplus Nontargeting Pool siRNA (Dharmacon, D-001810-10-50) at a final concentration of 100 nM. Transfections were conducted with Lipofectamine® RNAiMAX Transfection Reagent (Cat #13778150, LTX).
Gene expression microarray
Differentially expressed genes were identified by comparing HUVECs from GDM and control groups by using the HumanHT-12 v4 Expression BeadChip technology (Illumina, BD-103-0204) according to the manufacturer's instructions. The arrays were scanned by the Illumina iScan system, and Illumina's Genome Bead Studio TM Software was used for further data processing. To determine differential gene expression, a one-way analysis of variance (;t test) was performed, and all gene expression microarray data were deposited into the Gene Expression Omnibus repository (GEO #GSE87295).
Statistics
Data are generally presented as means 6 standard error of the mean (SEM) from different biological experiments. All normal comparisons between groups were assessed via twotailed t test, with P , 0.05 generally being considered significant.
Results
Isolation and characterization of primary cells from umbilical cords of GDM and healthy mothers
To study the effects of maternal hyperglycemia on the offspring at birth, we isolated mesenchymal stem cells (MSCs) from the Wharton's jelly and human Decreased cell proliferation of HUVECs, lower glucose uptake, and oxygen consumption in both primary cell types isolated from GDM subjects Hyperglycemic conditions have been shown to influence endothelial cell proliferation (22), and we carried out a comparative approach by assessing the proliferation rates of WJMSCs and HUVECs isolated from GDM and normal groups over a course of 7 days. We found there were no differences for the WJMSCs [ Fig.  1(a) ], but a significant difference (P ,0.05) for the HUVECs. As shown in [ Fig. 1(b) ], the GDM group of HUVECs exerted a lower proliferation rate compared with the normal control group (N = 6 per group). Because we aimed to further evaluate the GDM offspring's phenotypic profile, we measured insulin-dependent glucose uptake as a reflection of insulin sensitivity upon treatment with 100 nM insulin. When we compared insulinmediated glucose uptake, the GDM-derived WJMSCs and HUVECs had lower glucose uptake rates than normal controls [ Fig. 1(c) and 1(d)] . A key feature of Figure 1 . Lower metabolic activity of primary umbilical cord-derived cells from GDM offspring. Cellular proliferation of (a) WJMSCs and (b) HUVECs from GDM and normal groups was determined over 7 days (N = 6 per group; *P , 0.05). Error bars denote SEM. (c, d) Glucose uptake was measured in (c) WJMSCs (N = 7 per group, *P , 0.05) and (d) HUVECs from the GDM and normal groups 6 hours after acute 100 nM insulin treatment (N = 4 per group, *P , 0.05, error bars denote SEM). (e, f) Cellular OCR was measured in (e) WJMSCs (N = 5 GDM vs. 7 normal, *P ,0.05) and (f) HUVECs (N = 5 per group) from GDM and normal groups. P values were obtained by Student t test, error bars denote SEM. All readings were normalized to the total protein content of each well.
endothelial dysfunction is a compromised mitochondrial function (23) , which can be assessed by measuring the cellular OCR. As shown in [ Fig. 1 (e) and 1(f)], basal OCR in both WJMSCs and HUVECs with GDM background showed a lower OCR compared with the control group, with the difference in the WJMSCs reaching statistical significance (P , 0.05).
WJMSCs and HUVECs from GDM subjects harbor risk markers for cardiovascular disease ROS are a major cause of endothelial dysfunction induced by hyperglycemia (24) . We therefore investigated the ROS levels in our primary cell lines from both GDM and non-GDM groups to understand whether maternal hyperglycemia would affect the offspring's ROS production reflecting an increase in oxidative stress. Under basal conditions, both cell types from the GDM group exhibit a higher amount of ROS than normal controls [ Fig. 2(a) and 2(b) ]. Because oxidative stress can negatively affect cardiovascular function by disturbing angiogenesis, we addressed this question by growing HUVECs from both groups on cell culture dishes coated with Matrigel. Under these conditions, endothelial cells form tubes, which reflect the cell's propensity to build blood vessel-like structures. As depicted in [ Fig. 2(c) ], we found that tube formation was compromised in GDM-derived HUVEC lines. Microscopic images were taken [ Fig. 2(c) ], which were processed and quantified [ Fig. 2(d) ].
GDM causes genome-wide changes in gene expression pattern with enrichment of pathways reflecting angiogenesis and heart contraction In light of the striking differences observed for the endothelial cells from the GDM group, we conducted gene expression microarray experiments by using the HUVECs established from umbilical cord material derived from both groups of infants (GDM and control). As shown in Supplemental Table 1 , we selected five severe GDM cases from our specimen collection based on high oral glucose tolerance test values and compared them with the control group. As shown by principal component analysis, the individual transcriptomes studied were different, and putative GDM associations are circled (Supplemental Fig. 1A ). Our gene scatter (volcano) plot analysis revealed that the GDM group harbored more significantly upregulated genes compared with the normoglycemic group (Supplemental Fig. 1B) , which clustered significantly (P ,0.05) into separate groups (Supplemental Figure 1C) . A total of 250 of the most important differentially expressed genes (up and down) comparing GDM and control HUVEC lines were selected for pathway gene ontology (GO) analysis. The results shown in Table 2 revealed an enrichment of "angiogenesis" (P = 1.34E-11) and other pathways relevant to cardiovascular disease such as "negative regulation of heart contraction" (P = 4.01E-10) and "blood Figure 2 . Umbilical cord-derived primary cells from GDM offspring harbor increased levels of ROS and compromised tube formation activity. ROS levels were assessed in (a) WJMSCs (N = 6 GDM vs. 7 normal, *P , 0.05) and (b) HUVECs from GDM and normal groups (N = 5 in each group), as described in Methods (P ,0.05 by Student t test). Error bars denote the SEM. All readings were normalized to the total protein content of each well. (c) Light microscopy low-power (LP) field image of four normal and four GDM-derived HUVEC lines grown on Matrigel. (d) The average number of branches and tube lengths were quantified as described in Methods (N = 5 GDM vs. 6 normal; P values were calculated by Student t test; error bars denote SEM; *P ,0.05).
vessel development" (P = 2.54E-09). Furthermore, enrichment analysis by "diseases (by biomarkers) networks" for 250 of the most significantly different genes revealed pathways such as "wounds and injuries," "vascular diseases," and "cardiovascular diseases," which are all potentially important for cardiovascular biology (see Supplemental Table 2 ). In addition, analysis by "biological process networks" revealed "development regulation of angiogenesis" as one of the three top hits (Supplemental Table 3 ).
Cell surface protein CD44 is significantly downregulated in HUVECs derived from the GDM group and regulates tube formation, cell proliferation, and oxidative metabolism
Because pathways relevant to aberrant cardiovascular function were enriched in our analysis, we selected the candidate gene CD44, one of the most differentially expressed genes in the data set [ Fig. 3(a) ]. We validated by quantitative RT-PCR that CD44 was significantly downregulated in the GDM HUVECs (0.3 fold change 6 0.06 SEM) when compared with the controls (1.5 fold change 6 0.5 SEM) [ Fig. 3(b) ].We observed the same trend for the protein expression of CD44, which was found to be significantly lower (P ,0.05) in the GDM group (1.02 6 0.32 SEM) compared with the normal control (2.41 6 0.41 SEM) [ Fig. 3(c) ]. Next, we studied whether any of the different cellular phenotypes observed between the GDM and non-GDM HUVECs could be explained by altered CD44 expression. Hence, we evaluated functional effects of CD44 depletion on tube formation, cellular proliferation, and ROS production. We targeted CD44 messenger RNA (mRNA) in normal HUVECs, because they were shown to possess elevated CD44 expression levels compared with the GDM group [ Fig. 3(b) ]. On transfection of siRNAs directed against CD44, its mRNA and protein expression levels were substantially decreased almost sevenfold when compared with the scrambled siControl oligonucleotide transfected cell lines [ Fig. 4(a) , right and left panels].
We next addressed the functional consequences of CD44 depletion in our cell-based assays. First, we measured the effect of CD44 knockdown on tube formation activity. Compared with the control samples transfected with the scrambled siRNA construct, tube formation was impaired in the siCD44 transfected cells [shown are the results for two selected cell lines, Fig. 4(b) ]. Quantification by the ImageJ software (see Materials and Methods) revealed that the average number of branching points of the tubes was significantly lower (N = 4, P ,0.05) in the siCD44-transfected cells, whereas the tube lengths were unaffected [ Fig. 4(b), right panel] . As shown previously in Fig. 1(b) , GDM-derived HUVECs exhibited slower proliferation compared with their normal counterparts, and we assessed the effects of CD44 depletion on the growth rate of normal HUVECs. We found that cellular proliferation decreased upon CD44 knockdown [ Fig. 4(c) ], which indicates that CD44 may play a role in negatively regulating cell growth in the context of GDM. Because ROS levels were found to be upregulated in the GDM-derived HUVECs, we speculated that CD44 could regulate this process. However, no significant differences in ROS production were found in case of the CD44 depletion (data not shown). But CD44 depletion was found to reduce cellular oxygen consumption in two selected HUVEC cell lines [ Fig. 4(d) ], indicating that CD44 promotes mitochondrial oxygen consumption and oxidative phosphorylation.
HUVECs from the GDM group harbor lower levels of BCL-xL protein
The impairment of angiogenic activity in GDMderived HUVECs may be caused by increased cellular apoptosis compared with control cells. Although no morphological changes were observed for HUVECs in both groups, we assayed the expression levels of several proapoptotic and antiapoptotic proteins in representative cell lines from both groups. Interestingly, although the expression levels of most apoptotic regulators were not different between the groups, the antiapoptotic protein BCL-xL was found to be significantly reduced in the HUVECs from the GDM group (Fig. 5 , with quantification of western blot data shown on the right). This suggests a preexisting loss of protection against apoptosis, which may negatively affect the ability of GDMderived HUVECs to form tubes, a finding in line with the published observation that BCL-xL promotes angiogenesis in cancer cells (25) .
Potential complex mechanisms governing CD44 expression and its downstream effects on tube formation
In an attempt to gain more mechanistic insight into what causes the lower expression of CD44 in the GDM group of HUVECs, we treated normal HUVECs in vitro with high glucose (Supplemental Fig. 2A ) and with a mixture of fatty acids, which are known contributors to insulin resistance (Supplemental Fig. 2B ). Our results revealed no direct influence of these factors in isolation on the expression of CD44 in our cell line model, reflecting the increased complexity of the GDM condition in vivo. Park et al. (26) demonstrated for colorectal cancer cell lines that CD44 depletion led to the downregulation of BCL-xL. We tested whether a similar pathway may exist in our nontransformed normal HUVECs treated with CD44 siRNAs and again found no evidence for this pathway (Supplemental Fig. 2C ). Understanding the causes for the lower expression levels of CD44 and BCL-xL in HUVECs from GDM subjects and how they exert their molecular effects on tube formation will take more detailed investigations in future.
Discussion
Our data clearly demonstrate that maternal GDM is associated with cellular and transcriptomic changes found in umbilical cord-derived primary cells of the offspring. In our experimental system, we compared HUVECs and WJMSCs isolated from the umbilical cords of GDM and control offspring. Multiple reports have revealed that infants born to mothers with GDM demonstrate a higher risk for the development of cardiovascular disease (27, 28) . Our laboratory has demonstrated the versatility of WJMSCs for research in the field of developmental origins of health and disease, because they preserve cellular features reflecting suboptimal intrauterine conditions (14) . WJMSCs are multipotent and therefore possess the potential for lineage-specific differentiation (19) . In the basal, nondifferentiated state, we noted decreased glucose uptake and mitochondrial oxygen consumption, as well as increased ROS levels in the WJMSCs and HUVECs isolated from GDM offspring. Because increase in ROS is related to adverse vascular function (29) , and endothelial cells found in the cord may reflect characteristics of the offspring's vascular system (30), we investigated how maternal hyperglycemia might influence the transcriptome, as well as particular functions in HUVECs. In line with our experimental observation of compromised tube formation in GDM-derived HUVECs, the gene expression enrichment analysis from our expression array comparing HUVECs from both groups revealed that angiogenesis and pathways related to vascular development were the most significantly different. Constitutively high and brief fluctuating levels of glucose have been associated with a positive influence on ED (31) and the generation of ROS (32) , which may explain why we observed the significant increase in basal ROS levels in the GDM-derived HUVECS and WJMSCs.
Interestingly, we found an additional molecular environment that could promote atherosclerosis, such as pathways related to neutrophil and granulocyte recruitment, as well as cellular adhesion and inflammation, which were found to be enriched in the differentially expressed genes between GDM and normal control HUVECs. We selected the most important differentially expressed genes from the gene expression microarray study and validated them by RT-PCR. We focused our subsequent attention on the gene CD44, which is a Hyaluronan (HA) receptor found on endothelial cells and downregulated in our HUVECs derived from GDM cases. By anchoring HA to the endothelial cell, it maintains the composition and function of the glycocalyx, which is a complex mixture of various mucopolysaccharides including HA existing in the vasculature lining of the endothelium (33, 34) . Under conditions of shear stress in the vasculature, the glycocalyx is able to expose adhesion molecules to leukocytes, which can promote inflammation and hence the formation of atherosclerotic plaques (35) . In tumor biology, CD44 was shown to positively regulate angiogenesis (36) . A lower expression of CD44 in the context of GDM may negatively influence the control of angiogenesis and therefore compromise a healthy functioning of the endothelium and the ability to sustain collateral vessel growth. CD44 has hitherto not been described to be a gene influenced by developmental fetal programming, and its potentially pathological role in mediating ED warrants further investigation. We cannot exclude other genes or factors causing the impairment of tube formation for HUVECs with GDM background. In the pilot group used in the cellular assays and the gene expression microarray experiment, the maternal body mass index was not significantly different between the groups, nor were the offspring's anthropocentric measurements such as birthweight and birth length. All primary cell lines showed no morphological differences when cultured, but it is interesting to note that the expression of the antiapoptotic protein BCL-xL was reduced in the group of GDM-derived HUVEC lines, which may indicate a preexisting feature of prior exposure to hyperglycemia and a contributor to tube formation impairment. Angiogenesispromoting functions in tumors have been reported for BCL-xL (25) , and hence our data indicate that multiple mechanisms are at work to mediate cardiovascular health risk. In conclusion, we have shown that maternal GDM negatively affects molecular pathways in the offspring's umbilical cord. We also would like to highlight their potential versatility to serve as stratification biomarkers or therapeutic intervention targets, although more work must be carried out in the future to further substantiate hypotheses such as the roles of CD44 and BCL-xL and their molecular mechanisms in the context of GDM and cardiovascular disease.
